Scienture Holdings Inc Receivables Turnover Ratio (SCNX), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Scienture Holdings Inc   (NASDAQ: SCNX)
 

Scienture Holdings Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Scienture Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 1.15, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Scienture Holdings Inc in Jun 30 2026 quarter, has decreased to 317 days, compared to 392 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 506 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Scienture Holdings Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCNX Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change - -82.15 % -82.38 % -86.93 % -
Y / Y Revenue Change - 449.08 % - 809.71 % -
Receivable Turnover Ratio (TTM) 1.15 0.93 0.32 0.3 0.04
SCNX's Total Ranking # # # # # 864
Accounts Receivable average collection period days 319 390 1135 1227 9049
Seq. Receivable Change 13.88 % -1.2 % 23.94 % - -
Seq. Revenue Change 510.1 % - - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 167
Healthcare Sector # 507
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
15.48 9.6 0.47
(Sep 30 2023)   (Dec 31 2016)





SCNX Company Profile • Back to SCNX Efficiency Comparisons • Compare SCNX Receivables Turnover Ratio to its Competitors

Financial Statements
Scienture Holdings Inc 's Accounts Receivable $ 1 Millions Visit SCNX's Balance sheet
Scienture Holdings Inc 's Sales TTM $ 1 Millions Visit SCNX's Income Statement
Sources of SCNX's Revenues Visit SCNX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SCNX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SCNX's Growth Rates SCNX's Roa SCNX's Inventory Turnover Ratio SCNX's Dividend Comparisons
SCNX's Profitability Ratios SCNX's Roi SCNX's Asset Turnover Ratio SCNX's Dividend Growth
SCNX's Valuation Ratios SCNX's Roe SCNX's Financial Strength Ratios SCNX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Harrow Inc   2.69 $ 274.724  Millions$ 102.078  Millions
Electromed Inc   2.68 $ 72.076  Millions$ 26.868  Millions
Surrozen Inc   2.66 $ 11.511  Millions$ 4.329  Millions
Regeneron Pharmaceuticals Inc   2.62 $ 15,534.700  Millions$ 5,931.150  Millions
Onemednet Corporation  2.61 $ 1.590  Millions$ 0.609  Millions
Aclarion Inc   2.57 $ 0.084  Millions$ 0.033  Millions
Journey Medical Corp  2.50 $ 68.181  Millions$ 27.251  Millions
Astrotech Corp  2.49 $ 0.914  Millions$ 0.367  Millions
Cardiff Oncology Inc   2.49 $ 0.508  Millions$ 0.204  Millions
Tg Therapeutics Inc   2.34 $ 799.536  Millions$ 341.156  Millions
Cumberland Pharmaceuticals Inc   2.27 $ 31.269  Millions$ 13.764  Millions
Profound Medical Corp   2.22 $ 19.086  Millions$ 8.601  Millions
Lightwave Logic Inc   2.18 $ 0.250  Millions$ 0.115  Millions
60 Degrees Pharmaceuticals Inc   2.13 $ 1.111  Millions$ 0.522  Millions
Cardio Diagnostics Holdings Inc   2.10 $ 0.014  Millions$ 0.007  Millions
Arbutus Biopharma Corp  2.02 $ 181.720  Millions$ 89.755  Millions
Aytu Biopharma Inc  1.99 $ 55.515  Millions$ 27.912  Millions
EBR Systems, Inc.  1.97 $ 6.446  Millions$ 3.269  Millions
Scilex Holding Company  1.93 $ 31.608  Millions$ 16.396  Millions
Ocular Therapeutix Inc   1.79 $ 52.054  Millions$ 29.007  Millions
Heron Therapeutics Inc   1.76 $ 151.507  Millions$ 85.975  Millions
Bio Green Med Solution Inc   1.75 $ 1.861  Millions$ 1.061  Millions
Cytomx Therapeutics Inc   1.75 $ 18.302  Millions$ 10.446  Millions
Prophase Labs Inc   1.59 $ 3.150  Millions$ 1.977  Millions
Amarin Corp Plcuk  1.49 $ 186.480  Millions$ 125.559  Millions
Scienture Holdings Inc   1.35 $ 0.821  Millions$ 0.607  Millions
Regen Biopharma Inc   0.99 $ 0.237  Millions$ 0.239  Millions
IMPACT BIOMEDICAL INC.  0.69 $ 0.035  Millions$ 0.051  Millions
Cardiff Lexington Corporation  0.46 $ 10.213  Millions$ 22.347  Millions

Date modified: 2026-10-15T05:23:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.